| Name | vilazodone |
|---|---|
| Synonyms |
CleEyes
Vilazodonei with low price CAS NO.163-8 5‐{4‐[4‐(5‐Cyano‐1H‐indol‐3‐yl)‐butyl]‐1‐piperazinyl}‐2‐ benzofurancboxamide 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-cboxamide Vilozodone Vilazodone [inn] 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide VilazodoneQ: What is Vilazodone Q: What is the CAS Number of Vilazodone Q: What is the storage condition of Vilazodone Q: What e the applications of Vilazodone Vilazodone 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-cboxamide 5-{4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl}-1-benzofuran-2-carboxamide VILAZODONE Vilazodone, >= VILAZODONE API Velazolone 5-(4-(4-(5-Cyanoindol-3-yl)butyl)-1-piperazinyl)-2-benzofurancboxamide 5-(4-(4-(5-cyano-1H-indol-3-yl) butyl) piperazin-1- yl) benzofuran-2-cboxaMide hydrochloride 2-BenzofurancboxaMide,5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl] VIIBRYD; 5-(4-[4-(5-CYANO-1H-INDOL-3-YL)BUTYL]PIPERAZIN-1-YL)BENZOFURAN-2-CBOXAMIDE SB659746A|||EMD All Cle UNII-S239O2OOV3 AK-Con Velazolone hydrochloride Vilazodone, 10 mM in DMSO VILAZODONE //BP Vilazodone-d6 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-cboxamide Viibryd 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Vilazodonei Vilazodone HCL Verazodone hydrochloride 5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-cboxamide 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide VILAZODONE 163-8 |
| Description | Vilazodone (EMD 68843; SB 659746A) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.IC50 value:Target: SSRI; 5-HT1AVilazodone represents another option for the treatment of MDD. Vilazodone appears to have a favourable weight-gain profile based on short-term studies. Sexual side-effects were not consistently demonstrated when assessed using clinical rating scales but spontaneously reported AEs related to sexual functioning were observed. Additional controlled data regarding long-term efficacy and effectiveness will help characterise this new agent when used in maintenance treatment. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.34 g/cm3 |
|---|---|
| Boiling Point | 745.1ºC at 760 mmHg |
| Melting Point | 203-205ºC |
| Molecular Formula | C26H27N5O2 |
| Molecular Weight | 441.52 |
| PSA | 102.29000 |
| LogP | 5.53478 |
| Storage condition | -20°C |